Upcoming conferences

Trans-Hit Bio will be attending the USA East Coast Oncology Strategy Meeting
Cambridge - USA, Nov 18, 2019

Trans-Hit Bio will be attending the USA East Coast Oncology Strategy Meeting
Cambridge - USA, Nov 18, 2019

Trans-Hit Bio will be attending the UK Biobanking Showcase 2019
Nothingham, UK, Nov 19, 2019

Trans-Hit Bio will be attending the UK Biobanking Showcase 2019
Nothingham, UK, Nov 19, 2019

Come see us at the Molecular Med Tri-con, Booth 612
San Francisco - USA, March 2-4, 2020

PAST CONFERENCES

Trans-Hit Bio will be attending the Leaders in Biobankin Congres 2019
Miami - Florida, USA, Oct 30-Nov 1st, 2019

Trans-Hit Bio will be attending the Leaders in Biobankin Congres 2019
Miami - Florida, USA, Oct 30-Nov 1st, 20199

Trans-Hit Bio will be attending the XXXII Latin American Congress of Pathology
Lima, Peru, Oct 8-12, 2019

Trans-Hit Bio will be attending the XXXII Latin American Congress of Pathology
Lima, Peru, Oct 8-12, 2019

Trans-Hit will be at the 31st European Congress of Pathology
Nice - France, September 7-11, 2019

Trans-Hit will be at the 31st European Congress of Pathology
Nice - France, September 7-11, 2019

Come see us at The Next Generation DX Summit, Booth 200
Washington, DC, August 20-22, 2019


Dr. Vanessa Tumilasci will host a presentation on August 21st, @3:40 pm
''How Biospecimen Sourcing Can Impact Your R&D Programs''

Come see us at The Next Generation DX Summit, Booth 200
Washington, DC, August 20-22, 2019


Dr. Vanessa Tumilasci will host a presentation on August 21st, @3:40 pm (C4B: Companion Diagnostics and Clinical Biomarkers in Immuno-Oncology)
''How Biospecimen Sourcing Can Impact Your R&D Programs''

Biospecimen sourcing is becoming a challenge for many scientists who need to respect timelines for R&D plans as well as regulatory and ethical constraints. Are the scientists working with the samples aware of all the imperatives to obtain them; quality, respect of laws, ethics and regulations?

Come see us at World Pharma Week, Booth #232
Boston, MA USA, June 17-20, 2019

Trans-Hit Bio's Commercial Director, Dr. Vanessa Tumilasci will give a presentation: How Biospecimen Sourcing Can Impact Your R&D Results, June 18, 2019 @2:10 PM

Les 10èmes rencontres Toulousaines du Club 3C-R

Toulouse- France, June 4-5, 2019

Come meet us at the ISBER 2019 Annual Meeting
Shanghai - China, May 7-10, 2019

Dr. Huaijian (Alex) Guo (Trans-Hit Bio) will be chairing the symposium 'Utilization as a Key element to Biobank Sustainability: the Past, Present and Planning for Success in the Future'

Sustainability is a complex and ongoing challenge for biobanks around the world. Over the past several years, ISBER has been examining the dimensions of sustainability to help biobanks find solutions. One of the major issues is the low utilization rate of many of the world’s biobanks, regardless of the sector and size. Utilization can be defined in many ways, which makes it difficult to compare or define success for the use of collections. Each biobank has their own local constraints for use of their collections and what stakeholder communities that they can serve. Also, there are various metrics that can be employed to evaluate utilization of samples and data, and these will be discussed as part of the overall introduction to the complexity of pathways to sustainability for current and future biobanks. The invited speakers in the session will highlight their ongoing management of sustainability and how utilization targets and rates

9:00am-7:45pm Exhibit Hall Open Mandarin Hall 9:00am-12:00pm Symposium 3A:

Come meet us at ACCR Annual Meeting 2019
Atlanta, GA, March 29 - April 2nd, 2019

Come meet us at ACCR Annual Meeting 2019
Atlanta, GA, March 29 - April 2nd, 2019

Come see us at the Immuno-Oncology Summit Europe 2019, Booth 13
London - UK, March  18-22, 2019

Come see us at the Immuno-Oncology Summit Europe 2019,  Booth 13
London - UK, March  18-22, 2019

Come see us at the Biobanking 2019 event in Porto
Porto - Portugal, February 14-15, 2019
Robert Hewitt will give a presentation: Academic biobanks and industry: overcoming obstacles to efficient collaboration and mutual benefit

Thursday, February 14, 2019 at 16:40

Come see us at the Molecular Med Tri-con, Booth 612
San Francisco - USA, March 10-15, 2019
Vanessa Tumilasci, Director BD & Marketing will present:
How biospecimen sourcing can impact your R&D results?

Vanessa Tumilasci, Director BD & Marketing will present:
How biospecimen sourcing can impact your R&D results?
Tuesday, March 12 @ 11:55 AM

https://www.triconference.com/Preclinical-Immuno-Oncology-Biomarkers
Track: Liquid Biopsy & Immuno-Oncology: Immuno-Oncology Biomarkers & Companion Dx

Come meet Trans-Hit Bio at the World Biobanking Summit.
Berlin - Germany, November 29-30, 2018
Dr. Hewitt, Director Biobank (Chairperson) will host a presentation: Academic biobanks an industry: overcoming obstacles to efficient collaboration and mutual benefit.

 

 

December 13, 2018 - Trans-Hit Bio will host the webinar Analytical Validation of Blood and Tissue Biomarkers: Biospecimen Requirements

 

 

Trans-Hit Biomarkers, whose mission is to accelerate the development and validation of new biomarkers, has an objective to raise the awareness of the scientific community, both academia and industry, of the care they should take when using human specimens for discovering, developing and validating new biomarkers.

Following on from a well-received initial webinar, Trans-Hit Biomarkers now wants to provide participants with a better understanding of the studies required to achieve an appropriate analytical validation of blood biomarkers (immunoassays, blood-based genomic assays) and tissues biomarkers (immunohistochemistry). After hearing to three experts in biomarkers assays development, participants should be able to better understand the biospecimen needs and requirements for these studies.

Who Should Attend:
• Biomarker Scientists from academia or industry
• Biobanks: Pathologists, Clinical chemists, Managers
• Biospecimen Procurement department from Industry

Speakers
Dr. W. Jeffrey Allard, Ph.D. - Chief Executive Officer - Lakeside Life Science– USA
Dr. Mark Kockx, MD, Ph.D., Pathologist - Chief Executive Officer - HistoGenex, Belgium
Dr. Steve Kleiboeker, Ph.D. - Vice President - Research & Development - Viracor Eurofins Clinical Diagnostics - USA

Registration

Trans-Hit Bio will be attending the UKCRC Biobank Showcase
London - UK, November 27, 2018
Dr. Ann Cooreman, Trans-Hit’s Regulatory Affairs, QA and Project Manager will be present. Contact us if you would like to schedule a meeting with Dr. Cooreman

 

Come meet us at the 19th World Conference on Lung Cancer. (Booth #2108)
Toronto, Canada September 23-26, 2018

Trans-Hit Bio will be attending the Precision: Blood Cancer Summit
San Francisco. 18-19 September 2018.
Our Project Director Dr. Huaijian (Alex) Guo will be present. Contact us if you would like to schedule a meeting with Dr. Guo.

Come meet us at the 5th Precision Medicine & Biomarkers Leaders’ Summit
Munich - Germany, September 13-14, 2018

Come see us at the 1st Joint Meeting on Lung Cancer
Nice- France, September 6-7, 2018

Come see us at the 1st Joint Meeting on Lung Cancer
Nice- France, September 6-7, 2018

Trans-Hit Bio will be attending the Europe Biobank Week

Antwerp - Belgium, September 4-7, 2018
Presenting the abstract ''Can collaborating with Industry make Academic Biobanks sustainable? If so, what do they have to change to work with Industry?''

 

Trans-Hit Bio will be attending the Europe Biobank Week

Antwerp - Belgium, September 4-7, 2018

Presenting the abstract ''Can collaborating with Industry make Academic Biobanks sustainable? If so, what do they have to change to work with Industry?''

Come see us at The Next Generation DX Summit, Booth 407
Washington, DC, August 20-24, 2018


Dr. Vanessa Tumilasci will host a presentation on August 22, @2:50 pm
''Accelerating Biomarker Validation for Mid and Small size Dx Companies Through a Risk-Benefit Sharing Model''
 

 

Trans-Hit Bio will be attending the 2018 BIO International Convention in Boston. Boston - USA, June 4-7, 2018
Our Commercial Director Dr. Vanessa Tumilasci will be holding meetings at the Quebec Pavilion (#751).

Contact us to schedule a meeting.

Trans-Hit Bio will be attending the 2018 BIO International Convention in Boston. (June 4-7, 2018)
Our Commercial Director Dr. Vanessa Tumilasci will be holding meetings at the Quebec Pavilion (#751).

Contact us to schedule a meeting.

Les Rencontres Toulousaines 3CR
Toulouse - France, June 5-6, 2018

Les rencontres Toulousaines 3CR
Toulouse - France, June 5-6, 2018

Robert Hewitt will give a presentation:

''L’organisation en consortia de biobanques thématiques pour favoriser la recherche translationnelle ''

Mexico Biobanks Event
Mexico - Mexico, May 29-30, 2018
Presentation: Collaboration with industry: a solution for sustainability. How to adapt to their needs.

Mexico Biobanks Event

Mexico - Mexico, May 29-30, 2018

Presentation: Collaboration with industry: a solution for sustainability. How to adapt to their needs. Dr. Pascal Puchois

Trans-Hit Bio is attending the ISBER meeting in Dallas - USA
Dallas, USA, Mai 20-24 2018

A poster will be presented: 'Forming International Disease Specific Biobank Trusts to Ensure Long-Term Biobank Sustainability: Risk and Benefit Sharing Model'

Trans-Hit Bio is attending the ISBER meeting in Dallas - USA
Dallas, USA, Mai 20-24 2018

 

A poster will be presented: 'Forming International Disease Specific Biobank Trusts to Ensure Long-Term Biobank Sustainability: Risk and Benefit Sharing Model'

Come meet us at the 4th Global Precision Medicine & Biomarkers Leaders Summit
Boston, USA, May 7-8, 2018

Come meet us at the 4th Global Precision Medicine & Biomarkers Leaders Summit
Boston, USA, May 7-8, 2018

Come meet us at the Cancer Immunotherapy: Combinations Keystone Symposia  

Montreal, QC - Canada,  March 23-26, 2018

Come meet us at the Cancer Immunotherapy: Combinations Keystone Symposia

Berlin, Germany, 8-9 March, 201

Come meet us at the Global CDx & Personalized Medicine Summit

Berlin, Germany, 8-9 March, 2018

 

Robert Hewitt, Director Biobank Consortia and Communications at Trans-Hit Bio will host a presentation:

Academic biobanks and industry: overcoming obstacles to efficient collaboration and mutual benefit

Access to the recorded Webinar:
What Can go wrong when Sourcing Biospecimens?

Trans-Hit Bio, invites you to our Webinar on Overcoming Problems When Sourcing Biospecimens.

Webinar Description:

Personalization of medicine is driving the increase in demand for high-quality and well-annotated biospecimens. Biospecimen sourcing is becoming a challenge for many scientists (academic and private) who need to respect timelines for R&D plans as well as regulatory and ethical constraints. Industry has access to different biospecimen sourcing channels, each one has its pros and cons: are the scientists working with the samples aware of all the imperatives to obtain them; quality according to state-of-the-art procedures, respect of laws, ethics and regulations?

This webinar will discuss real cases of issues with the sourcing of biospecimens and how they can affect R&D projects. It will underline the need for traceability on biospecimen sourcing. The compliance with country-specific ethical and regulatory standards will also be discussed.

Upon completion of this Webinar, attendees should be able to:

  • Understand the risks of not being able to trace human biospecimens (scientific conclusions drawn from studies, corporate risks);
  • Better select their biospecimen providers by asking the right questions.

Speaker:

Dr. Ann Cooreman, Ph.D.
Regulatory Affairs and Project Management
Trans-Hit Bio

Dr. Cooreman holds an MA from Antwerp University (Antwerp, Belgium), and a PhD from the University of Oregon (Eugene, OR). Following on from various postdoctoral fellowships, she started her career in the Biobank field as a Project Manager for Scottish Biomedical with the primary responsibility of setting up a Tissue Bank. Afterwards Ann co-founded and led an international commercial biobank (UK) where she had a variety of corporate, business development, and operational responsibilities. While there, she supervised hundreds of projects for high profile clients, establishing privileged relationships with the most prestigious academic clinical sites and biobanks. In 2015, Ann became an independent consultant in ethics and regulatory affairs advising a number of academic and commercial entities or regulatory bodies. Ann joined Trans-Hit Bio ‘s multi-national team in January 2017. She is responsible for overseeing regulatory, ethical, and quality assurance issues and has supervised hundreds of biospecimen procurement projects for dozens of clients. She is instrumental in the development of THB’s European branch, partnering with key clients and biorepositories. Based on her actual experience, good and bad, she will present to the audience what can go wrong when sourcing biospecimens.

Cost: No cost.

 

Come see us at the 13th Annual Biomarkers Congress Booth 32
Manchester, UK, 15-16 February 2018

 

Come see us at the Molecular Med Tri-con, Booth 612
San Francisco - USA, February 11-16, 2018

Trans-Hit will host a presentation: 'How to Accelerate the Development of Blood Biomarker Candidates'

 

Monday February 12, 2018 at 4:10 PM 

Biobanking Seminar and Debate

Dublin - Ireland, January 11, 2018

Topics:
Structure and technical aspects of biobanks.
Value of biobanks to researchers, patients and commercial partners.
International models of biobanks and studies in oncology, genetics, cardiology.
Legal aspects of biobanks.

Venue: Fintan Gunne Lecture Theatre, Catherine McAuley Research Centre, Mater University Hospital, Dublin

Funded by the Health Service Executive
In association with:
Association of Clinical Biochemists in Ireland (ACBI)
 

Trans-Hit Bio to attend the Annual Biobank China 2017 
Changsha - China, Nov 30- December 3, 2017

Trans-Hit Bio participates at the Precision: Blood Cancer World R&D Summit
November 14-15, 2017 - San-Francisco – USA

Trans-Hit Bio  participates at the Precision: Blood Cancer World R&D Summit
November 14-15, 2017 - San-Francisco – USA

 

 

 

Trans-Hit Bio will present at the National Polish Biobank Conference

Wroclaw - Poland, October 13-14, 2017

Trans-Hit to attend the 2nd Annual Biomarkers & Precision Medicine USA Congress
San Diego, USA, 9-11 October

 

Come see us at Global Precision Medicine & Biomarkers leaders summit, Booth 1
Munich, Germany, September 21-22, 2017

 

 

Trans-Hit Bio to attend The Global Biobank Week
Stockholm, Sweden, September 13-15, 2017

 

Come see us at The Next Generation DX Summit, Booth 405
Washington, DC, August 15-18, 2017

Trans-Hit Bio will host a presentation at the Precision Lung Cancer Summit
Boston, July 25-26, 2017

 

Trans-Hit to attend the ASCO General Meeting
Chicago, IL, June 2-6, 2017

1) The importance of Reciprocal Transparency between Biobank and End Users of Samples
2) Tomorrow's need for Biospecimen in Pharma Research

 

 

 

Trans-Hit Bio attended: Global Precision Medicine Summit
Berlin, Germany, March 2-3, 2017

Trans-Hit Bio presented:
'How to expedite access to large biospecimen collections needed to validate liquid biopsy based assays' at The Molecular Medicine Tri Conference

San-Francisco, February 19-24, 2017. (Booth 605-607)

 

Trans-Hit Bio attended: 12th Annual Biomarkers Congress

Manchester, UK, February 21-22, 2017

Trans-Hit Bio Attended The ISBER 2016 Regional Meeting

Bethesda, MD, USA, November 7-8, 2016

Trans-Hit Attended The Europe Biobank Week
Vienna, Austria, September 13-16, 2016

Trans-Hit Attended The Next Generation DX Summit, Booth TT10

Washington, DC, USA, Augsut 23-26, 2016

Trans-Hit Hosted Two Presentations at The Biorepositories & Management Conference
Boston, MA, USA, September 5-7, 2016

Round table discussion:
Traceability of Biospecimen (patient - biobank - end-user): A need for Academic Biobank and Industry

Presentation:
Main impediments to increasing collaborations between Industry and Academic Biobank: some solutions